We are live on ! Find out more
BIOR

Biora Therapeutics, Inc. Common Stock
BIOR

Delisted

BIOR was delisted on the 10th of December, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of BIOR yet.

BIOR Hedge Fund Activity: Q4 2024 in Review

0 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Biora Therapeutics, Inc. Common Stock (BIOR) for Q4 2024, worth a combined $0 — down 100% from $6.13M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of BIOR and 0 opened new positions — a net loss of 19 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $350K sold.

  • 0 institutional investors held Biora Therapeutics, Inc. Common Stock (BIOR) as of Q4 2024, down from 20 in Q3 2024.
  • Funds reported $0 of Biora Therapeutics, Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Biora Therapeutics, Inc. Common Stock positions in Q4 2024 and 19 closed out, a net change of -19 holders.
  • The largest Biora Therapeutics, Inc. Common Stock seller in Q4 2024 was Vanguard Group, an estimated $350K sold.

Based on aggregated 13F filings for Q4 2024.